Transaction | Address | Amount |
---|---|---|
2eef30...515563
|
TMRTb7...LBh13i
|
-
340 USDT
·
339.81 USD
|
2eef30...515563
|
TVDErq...9sZLt2
|
+
340 USDT
·
339.81 USD
|
98ec07...07efb6
|
TAP9ir...h3ok2b
|
-
0.0101 USDT
·
0.01 USD
|
98ec07...07efb6
|
TMsSBn...g4ETcy
|
+
0.0101 USDT
·
0.01 USD
|
3aabfa...61924a
|
TRGaSF...NhiP69
|
-
20,290 USDT
·
20,278.93 USD
|
3aabfa...61924a
|
THyBe4...pL3udx
|
+
20,290 USDT
·
20,278.93 USD
|
1db875...3f81cd
|
TJpyEK...dMixou
|
-
17.1 USDT
·
17.09 USD
|
1db875...3f81cd
|
TQxdLK...T5UVHU
|
+
17.1 USDT
·
17.09 USD
|
a9f1c3...bf3651
|
TSEPVS...T4P2JU
|
-
375 USDT
·
374.79 USD
|
a9f1c3...bf3651
|
TSBvgg...kEe1NZ
|
+
375 USDT
·
374.79 USD
|
Tron Inc. shifts focus to a TRX-centered crypto treasury, registering $1 billion in securities.
Tron plans a $1 billion SEC filing, including a shelf registration. Here's why it matters.
Injective (INJ) targets $25 amid a bullish breakout attempt, hitting a five-month high of $16.35. Analysts predict a significant rally if key resistance levels are reclaimed. Still, failure to hold above certain thresholds might send prices down.